6 completed, 1 unknown. 7 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 6, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
Follow Placebo 1: new trials by email Literature Review of Placebo 1 trials Research Report on Placebo 1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Placebo-Controlled Arm Carbidopa 25 mg, Carbidopa-Levodopa 25/100 mg, Placebo 1 - Parkinsonian Signs in Older Persons | Phase 1 / Phase 2 | Completed | University of Michigan | 13 | 2024-03-15 | 2025-06-17 |
| A Phase 2 Study to Evaluate Pregabalin and Acetaminophen Compared to Acetaminophen and Placebo in Subjects Undergoing Bunionectomy Pregabalin, Acetaminophen, Placebo 1 - Postoperative Pain | Phase 2 | Completed | Nevakar, Inc. | 87 | 2020-07-28 | 2021-11-23 |
| Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease Otilimab, Placebo 1, Placebo 2 - Severe Acute Respiratory Syndrome | Phase 2 | Completed | GlaxoSmithKline | 1156 | 2020-05-28 | 2024-09-23 |
| Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder ACT-541468 5 mg, ACT-541468 10 mg, ACT-541468 25 mg - Insomnia Disorder | Phase 2 | Completed | Idorsia Pharmaceuticals Ltd. | 360 | 2016-10-04 | 2020-04-13 |
| A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome) Yiqi prescription, Huoxue prescription, Buyang huanwu decoction - Ischemic Heart Failure | Phase 2 | Unknown | Zhu Mingjun | 180 | 2016-06-01 | 2016-08-23 |
| Monotherapy With Rapamycin in Long-standing Type 1 Diabetes rapamycin, Vildagliptin, Placebo 1 - Diabetes Mellitus, Type 1 | Phase 2 | Completed | Piemonti Lorenzo | 55 | 2016-05-01 | 2020-11-04 |
| An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients VTP-43742, Placebo 1, Placebo 2 - Psoriasis | Phase 1 / Phase 2 | Completed | Vitae Pharmaceuticals Inc., an Allergan affiliate | 74 | 2015-08-01 | 2018-10-30 |
COVID-19 (1) · Coronary Artery Disease (1) · Coronavirus Infections (1) · Diabetes Mellitus, Type 1 (1) · Pain, Postoperative (1) · Psoriasis (1) · Severe Acute Respiratory Syndrome (1) · Sleep Initiation and Maintenance Disorders (1)
GlaxoSmithKline (1) · Idorsia Pharmaceuticals Ltd. (1) · Nevakar, Inc. (1) · Piemonti Lorenzo (1) · University of Michigan (1) · Vitae Pharmaceuticals Inc., an Allergan affiliate (1) · Zhu Mingjun (1)
United States (5) · Italy (2) · Spain (2) · Argentina (1) · Belgium (1) · Brazil (1) · Canada (1) · Chile (1) · China (1) · Colombia (1) · France (1) · Germany (1) · Hungary (1) · India (1) · Israel (1)
Chatkaew Pongmala, PhD (1) · Emanuele Bosi, MD (1) · Li Bin (1) · Lorenzo Piemonti, MD (1) · Richard Gregg, MD (1)
PMID 23741058, PMID 31953863, PMID 33124663, PMID 37477771, PMID 37526060, PMID 39175547
U01AG061393 (1)